论文部分内容阅读
目的:了解冠心病合并糖尿病的治疗方法;方法:选择48例冠心病患者,随机分为治疗组和对照组,每组24例。对照组采用常规指,依据患者血糖选择相应的治疗药物,可以在必要时进行胰岛素的皮下治疗,并应用硝酸异山梨醋。治疗组在对照组的基础上,采用瑞舒伐他汀。结果:两者患者治疗后的各项指标均得到明显改善,治疗组患者CRP、TC、LDL-C下降比较明显,HDL-C下降更明显;结论:瑞舒伐他汀可以有效地降低血清中的CRP,抑制斑块内炎症的发生,值得临床广泛应用。
Objective: To understand the treatment of coronary heart disease with diabetes mellitus. Methods: Forty-eight patients with coronary heart disease were randomly divided into treatment group and control group with 24 cases in each group. Control group using conventional means, based on the patient’s blood glucose to select the appropriate treatment drugs, when necessary, subcutaneous insulin treatment, and the application of isosorbide dinitrate vinegar. The treatment group on the basis of the control group, the use of rosuvastatin. Results: After treatment, the indexes of both groups were significantly improved. The CRP, TC and LDL-C in the treatment group decreased more obviously and the HDL-C decreased more obviously. Conclusion: Rosuvastatin can effectively reduce the serum levels of CRP, inhibit the occurrence of plaque inflammation, it is widely used in clinical.